Defective T helper activity in the spleen of BALB/c mice immune to a syngeneic fibrosarcoma
- PMID: 2954636
- PMCID: PMC11038320
- DOI: 10.1007/BF00205636
Defective T helper activity in the spleen of BALB/c mice immune to a syngeneic fibrosarcoma
Abstract
BALB/c mice were immunized with the syngeneic 3-methylcholanthrene-induced fibrosarcoma CA-2 by the growth and excision method. When lymphoid cells from different organs of these tumor-free mice were tested in a direct 51Cr-release assay, peritoneal exudate cells but not spleen cells displayed specific cytotoxicity against the syngeneic tumor target. A cytotoxic response could be obtained by tumor-immune spleen cells when cultured in a mixed lymphocyte tumor cell culture (MLTC) at high but not low density although at the same effector/stimulator ratio. Lack of cytotoxic activity in low density MLTC was not due to an impairment of cytotoxic precursors since cytotoxicity was rescued by adding exogenous interleukin-2 in experimental conditions in which no lymphokine-activated killer cells could develop relevant anti-CA-2 lysis. When low density MLTC were supplemented with either 800 R-irradiated cells or nonirradiated, negatively selected Lyt 1+ cells from the same immune mice, induction of a cytotoxic response against CA-2 occurred and interleukin-2 production became detectable. Additional studies indicated that spleen cells of CA-2-immune mice were also impaired in their ability to provide help to syngeneic thymocytes for the generation of cytotoxic T lymphocytes against C57BL/6J alloantigens. Dilution effect of helper cells due to immunization procedures was excluded since spleen cells of mice immunized against another BALB/c tumor, the YC8 lymphoma, or against DBA/2 minor histocompatibility antigens provided good help to thymocytes against the same alloantigens. These results indicate that tumor-immune animals may also have selective T helper defects in an important lymphoid organ like spleen.
Similar articles
-
Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.J Immunol. 1984 Jun;132(6):3218-25. J Immunol. 1984. PMID: 6202778
-
T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.Cell Immunol. 1983 Dec;82(2):378-93. doi: 10.1016/0008-8749(83)90171-5. Cell Immunol. 1983. PMID: 6197193
-
Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.J Immunol. 1987 Sep 15;139(6):2103-9. J Immunol. 1987. PMID: 2957448
-
Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.Eur J Immunol. 1976 Nov;6(11):823-9. doi: 10.1002/eji.1830061114. Eur J Immunol. 1976. PMID: 187429
-
Rejection of skin grafts and generation of cytotoxic T cells by mice depleted of L3T4+ cells.Transplantation. 1986 Dec;42(6):636-42. doi: 10.1097/00007890-198612000-00012. Transplantation. 1986. PMID: 2947360
Cited by
-
Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the host.Cancer Immunol Immunother. 1989;29(4):255-60. doi: 10.1007/BF00199213. Cancer Immunol Immunother. 1989. PMID: 2502309 Free PMC article.
References
-
- Bellgrau D, Zoller M. Cytotoxic T lymphocytes response to spontaneous tumors: immunogenicity dependent on the recognition of processed tumor antigens. J Immunol. 1983;130:2005. - PubMed
-
- Burger CJ, Elgert KD, Farrar WL. Interleukin-2 (IL-2) activity during tumor growth: IL-2 production, kinetics, absorption of and responses to exogeneous IL-2. Cell Immunol. 1984;84:228. - PubMed
-
- Carbone G, Colombo MP, Sensi ML, Cernuschi A, Parmiani G. In vitro detection of cell-mediated immunity to chemically induced BALB/c fibrosarcomas. Int J Cancer. 1983;31:483. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous